We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 15

China solicits comments on draft rules for writing Periodic Safety Update Reports

  • McDermott Will & Emery
  • -
  • China
  • -
  • April 10 2012

China’s State Food and Drug Administration recently issued draft guidance on drafting and preparing Periodic Safety Update Reports for drugs and is seeking comments from the public until 16 April 2012

China improves clinical trials and speeds up drug licensing

  • McDermott Will & Emery
  • -
  • China
  • -
  • April 5 2012

With increasing investment in research and development by foreign companies in China, assuring the reliability and efficiency of the drug and device development process is a critical priority

Medical devices: an introduction to the regulatory regime in China and options for foreign investors in the medical device sector

  • McDermott Will & Emery
  • -
  • China
  • -
  • September 16 2011

With the fast-growing medical device market in China, an increasing number of foreign investors are watching this industry

Shanghai Food and Drug Administration issues regulation for domestic processing and manufacturing of foreign pharmaceutical companies

  • McDermott Will & Emery
  • -
  • China, USA
  • -
  • September 7 2011

Following the State Food and Drug Administration (FDA)’s notice,“Enhancing Regulations for Domestic Processing and Manufacturing for Foreign Pharmaceutical Companies” (translation available upon request), the Shanghai FDA enacted its own regulations for Shanghai contract manufacturers of foreign pharmaceutical companies to ensure pharmaceuticals that are contract manufactured in China meet the drug standards of the United States

China issues draft administrative measures on national food safety standards; Shanghai strengthens food safety administration

  • McDermott Will & Emery
  • -
  • China
  • -
  • May 27 2010

Following the implementation of the 2009 Food Safety Law and its implementation rules, the last week of April 2010 brought another surge of attention on food safety in China

Liabilities for medical tort under PRC Tort Liability Law

  • McDermott Will & Emery
  • -
  • China
  • -
  • March 18 2010

The New Tort Liability Law of the People's Republic of China contains medical tort provisions that are of significance to medical institutions and their investors

Insurance and related protections for importers of Chinese goods

  • McDermott Will & Emery
  • -
  • China, European Union, USA
  • -
  • April 29 2008

Recalls of Chinese goods and litigation concerning defective products erode importers’ profits, threaten market share and damage established brands

How to claim damages under the Chinese court system

  • McDermott Will & Emery
  • -
  • China, USA
  • -
  • April 29 2008

Disputes involving products made in China have recently gained much attention in the global media

Congressional involvement increases in U.S.-China business relationships

  • McDermott Will & Emery
  • -
  • China, USA
  • -
  • April 29 2008

Recent scandals involving potentially dangerous products imported from China have heightened congressional activity, potentially affecting U.S.-China business relationships

Product safety and the EU - a problem with “made in China”?

  • McDermott Will & Emery
  • -
  • China, European Union
  • -
  • April 29 2008

As a result of recent Chinese product recalls, the European Commission has brought in a number of new initiatives to strengthen the enforcement of European Union product safety controls